Matthew Korenberg - 19 Aug 2024 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Rebecca J Hilt, Attorney-In-Fact for Matthew Korenberg
Issuer symbol
LFCR
Transactions as of
19 Aug 2024
Transactions value $
$0
Form type
4
Filing time
21 Aug 2024, 19:52:33 UTC
Previous filing
21 Aug 2024
Next filing
26 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award +24,554 24,554 19 Aug 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Vests on earlier of July 8, 2025 or the date of the annual meeting of stockholders of the Company first held in calendar year 2025 (provided such date is no less than 50 weeks from July 8, 2024).